Publication:
A preliminary study on the significant value of beta-2-microglobulin over serum creatinine in renal transplant rejection and renal failure

Date

2008

Journal Title

Journal ISSN

Volume Title

Publisher

Research Projects

Organizational Units

Journal Issue

Abstract

Introduction: Beta-2-microglobulin (β2M) is a light chain of HLA class I molecule, which is filtered by glomerulus, reabsorbed and catabolised by proximal tubule. It is one of the markers of transplant rejection. The aim of the present study was to find out the level of β2M in acute renal failure (ARF), chronic renal failure (CRF), renal transplant rejection (TR) and renal transplantation stable (TS) cases, and correlation of β2M with serum creatinine (SCr) in assessing renal failure. Methods: 23 patients with ARF, 22 patients with CRF, six cases of TR, seven patients with TS, and 28 normal healthy controls were studied within a one-year period. Results: Highest mean value of β2M was noted (12.97 +/- 3.83 μg/ml) in CRF, and all cases had elevated β2M of which 81.8 percent of cases had β2M above 10 μg/ml. In ARF, all cases had elevated β2M and 78.3 percent patients had a value more than 10 μg/ml with a mean value of 11.75 +/- 2.09 μg/ml. TR cases also had elevated β2M but 50 percent had mild elevation (less than 10 μg/ml) and 50 percent had marked elevation (more than 10 μg/ml). 42.8 percent of TS patients also had mild elevation of β2M in the range 2.10-3.70 μg/ml. Interestingly, in normal healthy controls, 21.4 percent of patients had mild elevation of β2M of 2.1-2.75 μg/ml, while 78.6 percent of cases had a normal range of β2M (less than 2 μg/ml). All normal healthy controls and 71.4 percent of TS cases had normal SCr (less than 1.4 mg/dL). All cases of CRF and TR cases, and 28.6 percent of TS cases had elevated SCr. 81.8 percent of cases with CRF and 60.9 percent of cases with ARF had a marked rise of serum creatinine above 5 mg/dL. Conclusion: Our study showed that β2M is not superior over SCr for renal failure and TR cases, because it is also elevated in 21.4 percent of normal controls and 42.8 percent of TS cases. SCr is a cheaper, simpler and comparatively good test to assess renal failure and TR.

Description

Keywords

Acute renal failure, Beta-2-microglobulin, Chronic renal failure, Renal transplant rejection, Serum creatinine

Citation

Collections